Stocks News

LAST PRICE
36.1900
TODAY'S CHANGE (%)
Trending Up0.2900 (0.8078%)

Bid / Lots
36.1800/ 1
Ask / Lots
36.2200/ 9
Open / Previous Close
35.7600 / 35.9000
Day Range
Low 35.6600
High 36.3500
52 Week Range
Low 33.3300
High 54.4446
Volume
319,996
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 14, 2024
- DJ Ionis Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 9:26AM ET on Thursday Nov 14, 2024 by Dow Jones
  9:26AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: IONS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IONS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 14, 2024 09:26 ET (14:26 GMT)
Nov 7, 2024
- DJ Ionis Pharmaceuticals Is Maintained at Overweight by Wells Fargo, from 10:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  10:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IONS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IONS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 10:30 ET (15:30 GMT)
- Ionis to present at upcoming investor conferences, from 7:05AM ET on Thursday Nov 07, 2024 by PR Newswire
  7:05AM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: IONS
  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
  https://mma.prnewswire.com/media/1735807/Ionis.jpg
- Ionis to present at upcoming investor conferences, from 7:05AM ET on Thursday Nov 07, 2024 by Dow Jones
  7:05AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IONS
  
  Ionis to present at upcoming investor conferences
  
  PR Newswire
  
  CARLSBAD, Calif., Nov. 7, 2024
  
  CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:
- DJ Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham, from 5:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  5:30AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: IONS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IONS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 05:30 ET (10:30 GMT)

Today
- ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 16 minutes ago by Accesswire
  16 minutes ago by Accesswire
  Companies Mentioned: ADMA
- ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 18 minutes ago by Dow Jones
  18 minutes ago by Dow Jones
  Companies Mentioned: ADMA
- TG Therapeutics to Participate in the Evercore HealthCONx Conference, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: TGTX
Nov 27, 2024
- The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:45PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: ADMA
- The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:45PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: ADMA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:15PM ET on Wednesday Nov 27, 2024 by Accesswire
  12:15PM ET on Wednesday Nov 27, 2024 by Accesswire
  Companies Mentioned: ADMA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:15PM ET on Wednesday Nov 27, 2024 by Dow Jones
  12:15PM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: ADMA
Nov 26, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 8:49PM ET on Tuesday Nov 26, 2024 by Accesswire
  8:49PM ET on Tuesday Nov 26, 2024 by Accesswire
  Companies Mentioned: ADMA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 8:49PM ET on Tuesday Nov 26, 2024 by Dow Jones
  8:49PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: ADMA
- DJ Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711, from 6:07PM ET on Tuesday Nov 26, 2024 by Dow Jones
  6:07PM ET on Tuesday Nov 26, 2024 by Dow Jones
  Companies Mentioned: ACAD

Ionis Pharmaceuticals Inc
NASDAQ:IONSUnited States

Search Criteria

Nov 14, 2024

DJ Ionis Pharmaceuticals Is Maintained at Overweight by Piper Sandler, from 9:26AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 7, 2024

DJ Ionis Pharmaceuticals Is Maintained at Overweight by Wells Fargo, from 10:30AM ET on Thursday Nov 07, 2024 by Dow Jones

Ionis to present at upcoming investor conferences, from 7:05AM ET on Thursday Nov 07, 2024 by PR Newswire

Ionis to present at upcoming investor conferences, from 7:05AM ET on Thursday Nov 07, 2024 by Dow Jones

DJ Ionis Pharmaceuticals Price Target Maintained With a $60.00/Share by Needham, from 5:30AM ET on Thursday Nov 07, 2024 by Dow Jones

Peers Headlines

Today

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 16 minutes ago by Accesswire

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm, from 18 minutes ago by Dow Jones

TG Therapeutics to Participate in the Evercore HealthCONx Conference, from 4 hours ago by Dow Jones

Nov 27, 2024

The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Accesswire

The Schall Law Firm Invites Stockholder Contributions To An Inquiry Into ADMA Biologics Inc's Securities Law Violations, from 12:45PM ET on Wednesday Nov 27, 2024 by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:15PM ET on Wednesday Nov 27, 2024 by Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 12:15PM ET on Wednesday Nov 27, 2024 by Dow Jones

Nov 26, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 8:49PM ET on Tuesday Nov 26, 2024 by Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA, from 8:49PM ET on Tuesday Nov 26, 2024 by Dow Jones

DJ Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711, from 6:07PM ET on Tuesday Nov 26, 2024 by Dow Jones